Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Obesity, a pervasive health concern, has been identified as a significant risk factor for ATAAD, introducing unique surgical challenges that can influence postoperative outcomes. Based on BMI (WS/T 428-2013), patients were categorized into normal weight, overweight, and obese. Results The average age of the cohort was 50.1 ± 11.2

Obesity 64

Obesity Aortic BMI Outcomes 64

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background The obesity occurrence has achieved epidemic levels worldwide and several studies indicate a paradoxical similarity among obesity and the prognosis in heart failure (HF). Methods We analyzed 1,556 medical records from the HF outpatient clinic of a quaternary hospital and 242 were selected according to the criteria.

Outpatient 59

Outpatient Obesity Heart Failure BMI 59

Medical Xpress - Cardiology

APRIL 2, 2024

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well.

Heart Disease 104

Heart Disease Obesity Cardiovascular Disease Diabetes 104

HCPLive

JUNE 6, 2024

The retrospective analysis highlights improved outcomes among patients with obesity and a history of bariatric surgery hospitalized with decompensated cirrhosis.

Hospital 52

Hospital Obesity Outcomes 52

Becker's Hospital Review - Cardiology

AUGUST 27, 2024

22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics. GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug.

Pharmacology 113

Pharmacology Obesity Diabetes 113

Journal of the American Heart Association

DECEMBER 29, 2023

AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited.

Obesity 45

Obesity Atrial Fibrillation Heart Failure Pharmacology 45

HCPLive

NOVEMBER 16, 2024

Tirzepatide reduced the risk of heart failure hospitalization or cardiovascular death by 38% and improved body weight by up to 21% in the SUMMIT trial.

Obesity 59

Obesity Heart Failure Hospital 59

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Circulation: Heart Failure

OCTOBER 27, 2023

The role of obesity in RV dysfunction and adverse outcomes is unclear.METHODS:We examined patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort. years of follow-up, we observed 3006 mortality and 2004 heart failure hospitalization events. Over median of 7.3 per 1-SD increase [95% CI, 1.04–1.18]),

Obesity 40

Obesity Outcomes Heart Failure Pulmonary 40

Stroke Journal

FEBRUARY 1, 2024

Meanwhile, Metabolically healthy obesity (MHO) trends are understudied in association with stroke. Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Background:Obesity has been associated with an increase in the risk of stroke and poor outcomes.

Obesity 40

Obesity Hospital Strokes Stroke 40

Open Heart

JUNE 9, 2023

Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. kg/m 2 and 23.2% (255) were categorised as obese. On multivariable analysis, obesity showed paradoxical protective effect with adjusted OR of 0.59 (95% CI 0.36 to 7.15, p=0.007).

Obesity 40

Obesity BMI Hospital Thrombosis 40

Journal of the American Heart Association

JANUARY 10, 2025

Many patients with NVAF are obese and manage other health conditions requiring multiple medications. Allcause HRU rates were significantly lower with rivaroxaban versus warfarin, and hospital stays were reduced by 3.1 Journal of the American Heart Association, Ahead of Print. days with rivaroxaban.

Atrial Fibrillation 40

Atrial Fibrillation Obesity Medicare Hospital 40

Circulation

NOVEMBER 11, 2024

Background:Metabolic syndrome and obesity are known to increase the incidence of lung cancer. We investigated the association between metabolic health and overweight/obesity phenotypes and clinical outcomes in patients with resectable non-small cell lung cancer (NSCLC).Methods:This 0.98, p = 0.040; MUO: adjusted HR 0.76, 95% CI 0.60-0.96,

Obesity 40

Obesity Cancer Outcomes Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Rising obesity rates and the increasing prevalence of stroke in the metabolically healthy obese (MHO) necessitate examining its association in younger (18-44 year) populations. Most were hospitalized in southern US urban teaching hospitals.

Obesity 40

Obesity Strokes Stroke Outcomes 40

DAIC

MARCH 29, 2024

"We're pleased to present the RELIEVE-HF data at this year's ACC meeting, as we continue to advance this important technology with the goal of bringing a much-needed treatment option to patients with advanced heart failure, a leading cause of death and hospitalization in the U.S. and worldwide," said Neal Eigler, M.D. , CEO of V-Wave.

Preserved Ejection Fraction 111

Preserved Ejection Fraction Heart Failure Quality of Life Hospital 111

DAIC

JANUARY 29, 2024

We wanted to know if this survival benefit of multi-arterial grafting observed in single-center studies would translate to a large national cohort,” said the study’s lead author, Joseph Sabik III , MD, University Hospitals. The only patients where single arterial grafting resulted in better survival were severely obese,” said Dr. Sabik.

Coronary Artery Bypass Graft 105

Coronary Artery Bypass Graft Research BMI Obesity 105

Stroke Journal

JANUARY 30, 2025

However, TTEs are not always readily available, can delay hospital discharge, and increase the cost of each hospitalization. Introduction:Determining ischemic stroke etiology using transthoracic echocardiography (TTE) is often considered to be a standard part of routine stroke care and secondary prevention of stroke.

Hospital 40

Hospital Strokes Stroke Inpatient 40

DAIC

MARCH 26, 2025

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients (REDEFINE-HF). 4 Approximately 6.7 million adults in the U.S. NCT 06008197.

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

The British Journal of Cardiology

AUGUST 6, 2024

Atrial fibrillation (AF) is responsible for significant patient morbidity, and obesity is a major contributor to AF incidence and symptom burden. This randomised study set out to examine if smartphone-based app technology could increase weight loss in a patient population with obesity and AF.

Atrial Fibrillation 49

Atrial Fibrillation Obesity Quality of Life Outpatient 49

European Journal of Heart Failure

OCTOBER 9, 2024

CI, confidence interval; CVD, cardiovascular disease; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HHF, hospitalization for heart failure; HR, hazard ratio; NYHA, New York Heart Association. Obesity did not modify the effects of EQW on HHF. The risk of HHF was also modified by baseline NYHA class (HR 0.91, 95% CI 0.65–1.27

Diabetes 75

Diabetes Outcomes Heart Failure Obesity 75

Becker's Hospital Review - Cardiology

DECEMBER 2, 2024

With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound can address outcomes in cardiovascular health.

Outcomes 64

Outcomes Obesity Heart Disease Research 64

Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

Semaglutide treatment was found to reduce healthcare costs significantly for patients with overweight or obesity and who had either heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society's annual Obesity Week conference and reviewed Nov.

Heart Failure 52

Heart Failure Obesity Cardiovascular Disease 52

European Journal of Heart Failure

DECEMBER 22, 2023

Abstract Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are lower in patients with obesity. Hospitalization for heart failure (HHF) was examined across strata of baseline BMI and NT-proBNP.

Heart Failure 75

Heart Failure BMI Obesity Article 75

Journal of the American Heart Association

MARCH 26, 2025

kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). Considering patients with 1 SMuRF and obesity as the reference group, the group who were SMuRFless underweight exhibited the highest increase in mortality (adjusted OR, 3.854 [95% CI, 2.1306.973],P<0.001).ConclusionsAmong

Myocardial Infarction 40

Myocardial Infarction Risk Factors BMI Obesity 40

Stroke Journal

FEBRUARY 1, 2024

This observational study aims to investigate the association between income status in acute ischemic stroke (AIS) and cardiovascular events among young, hospitalized adults with dependent cannabis use or cannabis use disorder (CUD).Methods:We vs. 27.9%), visiting rural hospitals (13.9% vs. 12.7%), DM (8% vs. 6.6%), and obesity (10.9%

Hospital 40

Hospital Strokes Stroke Medicaid 40

CardiacWire

AUGUST 2, 2024

Lilly’s blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity. vs. +15 KCCQ-CSS points).

Outcomes 59

Outcomes Preserved Ejection Fraction Heart Failure Obesity 59

Journal of the American Heart Association

MARCH 27, 2025

Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Becker's Hospital Review - Cardiology

NOVEMBER 18, 2024

The GLP-1 tirzepatide, the active ingredient in Eli Lilly's Mounjaro, was found to reduce the risk of heart failure by 46% among individuals with obesity, according to a study published Nov. 16 in The New England Journal of Medicine and presented at the American Heart Association's annual Scientific Sessions.

Heart Failure 59

Heart Failure Obesity 59

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

We present the case of a 28-year-old obese Caucasian male who arrived at our hospital with significant pain and swelling in his right lower extremity. Inferior vena cava (IVC) agenesis is a rare congenital anomaly that has been implicated in up to 5% of unprovoked deep vein thrombosis (DVT) cases in young men under 30 years old.

Pulmonary 52

Pulmonary Risk Factors Thrombosis Ultrasound 52

Frontiers in Cardiovascular Medicine

JULY 22, 2024

Our study focuses on addressing this gap by evaluating adherence to OMT, examining its influence on the risk of MACEs after STEMI, and assessing subsequent cardiovascular risk factor control in Mexico.MethodsWe conducted a prospective observational study of post-STEMI patients after hospital discharge. Patients were followed up for 4.5

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

Physiologically Speaking

JANUARY 10, 2024

This is supported by studies showing that ALAN exposure is associated with a range of conditions like cardiometabolic disease, obesity, and diabetes. How could ALAN and the SCN affect cardiovascular health? Three main pathways predominate: melatonin release, the autonomic nervous system, and the endocrine (hormonal) system.

Blood Pressure 131

Blood Pressure Physiology Cardiovascular Disease Obesity 131

Circulation

JANUARY 22, 2025

Optimal NT-proBNP cut points for HFpEF rule out (optimizing sensitivity) and rule in (optimizing specificity) were derived and tested, stratified by obesity and atrial fibrillation. In our study, NT-proBNP provided little value in those with AF and dyspnea because the presence of AF is by itself a robust biomarker of HFpEF.

Preserved Ejection Fraction 55

Preserved Ejection Fraction Outpatient Heart Failure BMI 55

Journal of Cardiovascular Pharmacology

JUNE 24, 2024

Sodium/glucose cotransporter 2 (SGLT2) inhibitors are a novel class of anti-diabetic medications which have proved capable of providing breakthrough cardiovascular benefits in a variety of clinical scenarios, including patients with heart failure or obesity, irrespective of diabetic status.

Myocardial Infarction 40

Myocardial Infarction Heart Failure Pharmacology Diabetes 40

Stroke Journal

JANUARY 30, 2025

Hospital readmission rates can help identify the optimal strategy to minimize post-procedural complications. The purpose of this study is to analyze 30-day readmission rates in elective and nonelective CAS and CEA procedures.Methodology:The 2017 National Readmission Database is queried for hospital admissions for CAS and CEA procedures.

Stent 40

Stent Stents Lipid disorders Heart Failure 40

Stroke Journal

FEBRUARY 1, 2024

We aimed to compare in-hospital mortality and predictors in stroke patients with secondary rheumatological conditions.Methods:Using the National Inpatient Sample (NIS), we identified patients ≥18 admitted for stroke (Jan 2019 - Dec 2020), stratified into RA, SLE, scleroderma, or vasculitides groups using ICD-10-CM codes.

Inpatient 40

Inpatient Strokes Stroke Coronary Artery Disease 40

Dr. Paddy Barrett

SEPTEMBER 20, 2024

Except in the setting of type 2 diabetes, metabolic syndrome, insulin resistance and obesity. Using LDL cholesterol to guide your decisions is ok but not great. Usually LDL -C roughly equates to levels of ApoB. But My Doctor Doesn’t Test For ApoB. No problem. You have two options.

Heart Disease 111

Heart Disease Cholesterol Atherosclerosis Heart attacks 111

Heart 2023 Conference

JULY 17, 2021

"Pregnant ladies who have had bariatric surgical operation exhibit higher cardiovascular adaptation thru decrease blood pressure, heart rate, and cardiac output, greater favorable diastolic indices, and higher systolic function," stated Deesha Patel, MBBS MRCOG, expert registrar, Chelsea and Westminster Hospital, London, United Kingdom.

BMI 52

BMI Blood Pressure Obesity Outcomes 52